Page last updated: 2024-11-12

chikusetsu saponin iva

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

chikusetsu saponin IVa: from the tubers of Hemsleya pengxianensis (Cucurbitaceae) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Hemsleyagenus[no description available]CucurbitaceaeThe gourd plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida. It is sometimes placed in its own order, Cucurbitales. 'Melon' generally refers to CUCUMIS; CITRULLUS; or MOMORDICA.[MeSH]
Hemsleya pengxianensisspecies[no description available]CucurbitaceaeThe gourd plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida. It is sometimes placed in its own order, Cucurbitales. 'Melon' generally refers to CUCUMIS; CITRULLUS; or MOMORDICA.[MeSH]

Cross-References

ID SourceID
PubMed CID13909684
CHEMBL ID1095348
CHEBI ID67977
SCHEMBL ID2987898
MeSH IDM0258927

Synonyms (29)

Synonym
t3fu6zpr5v ,
51415-02-2
unii-t3fu6zpr5v
beta-d-glucopyranosiduronic acid, (3beta)-28-(beta-d-glucopyranosyloxy)-28-oxoolean-12-en-3-yl
chikusetsu saponin iva
chikusetsusaponin iva
chebi:67977 ,
CHEMBL1095348
chikusetsusaponin-iva
S9116
3-o-.beta.-d-glucuronopyranosyl)oleanolic acid 28-o-.beta.-d-glucopyranoside
.beta.-d-glucopyranosiduronic acid, (3.beta.)-28-(.beta.-d-glucopyranosyloxy)-28-oxoolean-12-en-3-yl
momordin iib
silphioside g
oleanolic acid 3-o-(.beta.-d-glucuronopyranosyl)-28-o-.beta.-d-glucopyranoside
calenduloside f
SCHEMBL2987898
CS-3821
AC-35098
HY-N0818
AKOS037514679
Q27136462
chikusetsu saponin a
DTXSID10965732
CCG-270487
(2s,3s,4s,5r,6r)-6-[[(3s,4ar,6ar,6bs,8as,12as,14ar,14br)-4,4,6a,6b,11,11,14b-heptamethyl-8a-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3,4,5-trihydroxyoxane-2
AS-77494
oleanolic acid 3-o-(beta-d-glucuronopyranosyl)-28-o-beta-d-glucopyranoside
3-o-beta-d-glucuronopyranosyl)oleanolic acid 28-o-beta-d-glucopyranoside

Research Excerpts

Effects

ExcerptReferenceRelevance
"Chikusetsu saponin IVa (CHS) has been defined as a major active ingredient of triterpenoid saponins extracted from Aralia taibaiensis."( Insulinotropic effect of Chikusetsu saponin IVa in diabetic rats and pancreatic β-cells.
Cao, SS; Cui, J; Duan, JL; Jia, N; Li, RL; Li, YW; Wang, C; Wang, L; Wen, AD; Weng, Y; Wu, Y; Xi, MM; Zhao, C, 2015
)
1.44

Pharmacokinetics

ExcerptReferenceRelevance
" The method was validated and successfully applied to the preliminary pharmacokinetic study of chikusetsusaponin V and chikusetsusaponin IV in rat plasma after oral administration of saponins extracted from Rhizoma Panacis Japonici."( Determination of chikusetsusaponin V and chikusetsusaponin IV in rat plasma by liquid chromatography-mass spectrometry and its application to a preliminary pharmacokinetic study.
Chen, J; Li, F; Qi, D; Shi, X; Yang, X; Yang, Z; Zhang, C, 2013
)
0.39
" This method was successfully applied in the pharmacokinetic study of CHS-IVa in rats."( Determination and validation of chikusetsusaponin IVa in rat plasma by UPLC-MS/MS and its application to pharmacokinetic study.
Guo, MH; Liu, SP; Wang, Y; Wang, Z, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
triterpenoid saponinA terpene glycoside in which the terpene moiety is a triterpenoid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (14)

Assay IDTitleYearJournalArticle
AID1607873Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS induced iNOS at 30 uM preincubated for 1 hr followed by LPS stimulation measured after 18 hrs relative to control2019European journal of medicinal chemistry, Oct-01, Volume: 179Human disorders associated with inflammation and the evolving role of natural products to overcome.
AID481001Cytotoxicity against human PANC1 cells at 25 uM after 48 hrs by WST8 assay2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.
AID595746Inhibition of fMLP/CB-stimulated superoxide anion generation in human neutrophils2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Bioactive constituents from the roots of Panax japonicus var. major and development of a LC-MS/MS method for distinguishing between natural and artifactual compounds.
AID480995Cytotoxicity against human A549 cells at 25 uM after 48 hrs by WST8 assay2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.
AID595752Cytotoxicity against human DU145 cells assessed as growth inhibition after 3 days by sulforhodamine B assay2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Bioactive constituents from the roots of Panax japonicus var. major and development of a LC-MS/MS method for distinguishing between natural and artifactual compounds.
AID538479Cytotoxicity against human HL60 cells by MTT assay2010Bioorganic & medicinal chemistry letters, Dec-01, Volume: 20, Issue:23
Oleanane-type triterpenoids from Panax stipuleanatus and their anticancer activities.
AID595748Inhibition of fMLP/CB-activated human neutrophil degranulation assessed as inhibition of elastase release using MeO-Suc-Ala-Ala-Pro-Val-p-nitroanilide as a substrate after 5 mins2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Bioactive constituents from the roots of Panax japonicus var. major and development of a LC-MS/MS method for distinguishing between natural and artifactual compounds.
AID480999Cytotoxicity against human HL60 cells at 25 uM after 48 hrs by WST8 assay2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.
AID480997Cytotoxicity against human PC3 cells at 25 uM after 48 hrs by WST8 assay2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.
AID595753Cytotoxicity against human A549 cells assessed as growth inhibition after 3 days by sulforhodamine B assay2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Bioactive constituents from the roots of Panax japonicus var. major and development of a LC-MS/MS method for distinguishing between natural and artifactual compounds.
AID595751Cytotoxicity against human KB cells assessed as growth inhibition after 3 days by sulforhodamine B assay2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Bioactive constituents from the roots of Panax japonicus var. major and development of a LC-MS/MS method for distinguishing between natural and artifactual compounds.
AID595754Cytotoxicity against human HCT8 cells assessed as growth inhibition after 3 days by sulforhodamine B assay2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Bioactive constituents from the roots of Panax japonicus var. major and development of a LC-MS/MS method for distinguishing between natural and artifactual compounds.
AID481003Cytotoxicity against human MRC5 cells at 25 uM after 48 hrs by WST8 assay2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.
AID538480Cytotoxicity against human HCT116 cells by MTT assay2010Bioorganic & medicinal chemistry letters, Dec-01, Volume: 20, Issue:23
Oleanane-type triterpenoids from Panax stipuleanatus and their anticancer activities.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (46)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (4.35)18.2507
2000's3 (6.52)29.6817
2010's32 (69.57)24.3611
2020's9 (19.57)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.58

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.58 (24.57)
Research Supply Index3.85 (2.92)
Research Growth Index5.43 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.58)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.17%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other45 (97.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]